Dalriada announced a strategic collaboration with a public computational company to apply its iCLASS proteomics platform combined with computational technologies for novel drug discovery. Separately, advances in agentic AI and digital twins are enhancing biomanufacturing by enabling autonomous real-time process optimization and integration of sensor data. These platforms provide precision in identifying druggable targets and improving manufacturing model accuracy, reflecting a trend towards AI-driven innovation in biotech R&D and production.